By Kaustubh Kulkarni MUMBAI (Reuters) - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week with broad consequences for their ability to sell lucrative patented medicines in the country. India's Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment